Non-invasive prenatal testing: MeDIP-PCR to detect trisomy 21 from maternal plasma
Introduction: Down syndrome is a predominant genetic disease with an incident rate of one in every 750 live births. This abnormality can be identified through non-invasive and invasive procedures. Currently, the use of cell-free fetal DNA (cfDNA) from maternal plasma is widely implemented as one of...
Main Authors: | Abdul Ghafar, Nurul Fatehah, Muhammad, Siti Aesah @ Naznin, A. Talib, Norlelawati, Roslani, Anna Liza, Ismail, Rozihan, Zainuddin, Norafiza |
---|---|
Format: | Conference or Workshop Item |
Language: | English English |
Published: |
2019
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/77018/ http://irep.iium.edu.my/77018/2/SLIDE%20PPT%20_taylor.pdf http://irep.iium.edu.my/77018/13/77018%20Non-invasive%20prenatal%20testing.pdf |
Similar Items
-
Identifying the DNA methylation differences in cell-free fetal DNA: an approach towards non-invasive prenatal diagnosis of trisomy 21 in Malaysia
by: Zainuddin, Malaysia, et al.
Published: (2019) -
Non-invasive prenatal testing using cell-free fetal DNA from maternal plasma: a review
by: Abdul Ghafar, Nurul Fatehah, et al.
Published: (2017) -
Knowledge on Down Syndrome and Down Syndrome prenatal screening tests among pregnant women in Kuantan, Pahang
by: Abdul Ghafar, Nurul Fatehah, et al.
Published: (2019) -
Fetal down syndrome: determining the risk based on fetal-specific DNA methylation ratio
by: Zainuddin, Norafiza, et al.
Published: (2019) -
Methylation-sppecific PCR assay for quantification of DNA methylation of SPG20 gene in colorectal cancer
by: Mamat, Maizatul Akma, et al.
Published: (2017)